WA
VRTX icon

WealthTrust-Arizona’s Vertex Pharmaceuticals VRTX Stock Holding History

WealthTrust-Arizona’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50
Closed -$6K – 668
2014
Q3 		$6K Hold
50
– – 0.01% 484
2014
Q2 		$5K Hold
50
– – 0.01% 496
2014
Q1 		$4K Hold
50
– – ﹤0.01% 527
2013
Q4 		$4K Hold
50
– – ﹤0.01% 511
2013
Q3 		$4K Hold
50
– – 0.01% 480
2013
Q2 		$4K Buy
+50
New +$3.68K 0.01% 463

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

WealthTrust-Arizona's VRTX Position: Q4 2014 in Review

WealthTrust-Arizona sold out of Vertex Pharmaceuticals (VRTX) in Q4 2014, closing a stake of 50 shares — an estimated $6K sold.

WealthTrust-Arizona first reported a position in VRTX in Q2 2013 and held it in 6 quarters. The position peaked at $6K in Q3 2014. 475 funds tracked by Wall St. Rank hold VRTX as of Q4 2014.

  • WealthTrust-Arizona reported no remaining Vertex Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • WealthTrust-Arizona sold 50 Vertex Pharmaceuticals shares in Q4 2014, an estimated $6K.
  • WealthTrust-Arizona first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • WealthTrust-Arizona's Vertex Pharmaceuticals position peaked at $6K in Q3 2014.
  • 475 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2014.

Based on WealthTrust-Arizona's 13F filing for Q4 2014, filed 22 Jan 2015.